Thiopyrimidinecarboxamides as CXCR1/2 modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8969365
SERIAL NO

13957665

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is disclosed a pyrimidinecarboxamide compound useful as a pharmaceutical agent, synthetic processes, and pharmaceutical compositions which include the pyrimidinecarboxamide compound. More specifically, there is disclosed a CXCR1/2 inhibitor useful for treating a variety of inflammatory and neoplastic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTRIX BIOSYSTEMS INC215 CLAY STREET NW SUITE B-5 AUBURN WA 98001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Maeda, Dean Y Seattle, US 19 121
Schuler, Aaron D Auburn, US 12 73
Zebala, John A Issaquah, US 38 403

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00